Physician profile
Adrianne Schepler Dirr
NPI 1093905606
$1,467.28
in general payments reported to CMS, 2019-2025
16 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.22 · 2020: $19.40 · 2021: $137 · 2022: $367 · 2023: $216 · 2024: $478 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613 · Entertainment: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.13 |
| Entertainment | $243.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $378.80 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Biofinity Contact Lens |
| Optos, INC. | $343.69 | 2022-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $162.56 | 2022-2025 | Infuse |
| Alcon Vision LLC | $134.45 | 2022-2025 | Total30, Precision7 |
| Lkc Technologies, INC. | $105.91 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $86.96 | 2021 | |
| Oyster Point Pharma, INC. | $42.37 | 2022 | |
| Sun Pharmaceutical Industries INC. | $35.43 | 2023 | Cequa |
| Lombart Brothers, INC. | $33.51 | 2023 | Opd-III |
| Abbvie INC. | $29.25 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $28.66 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.42 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Abb Con-Cise Optical Group LLC | $16.07 | 2019 | |
| Allergan, INC. | $13.62 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrianne Dirr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.